Atsushi Kurabayashi Selected Research

Neoplasms (Cancer)

2/2022	Current status of photodynamic technology for urothelial cancer.
3/2020	5-aminolevulinic acid-mediated photodynamic diagnosis using fluorescence ureterorenoscopy for urinary upper tract urothelial carcinoma ∼Preliminary prospective single centre trial∼.
8/2015	Combination with third-generation bisphosphonate (YM529) and interferon-alpha can inhibit the progression of established bone renal cell carcinoma.
5/2015	Observation of tissues in open aqueous solution by atmospheric scanning electron microscopy: applicability to intraoperative cancer diagnosis.
1/2015	Silencing of ATPase Inhibitory Factor 1 Inhibits Cell Growth via Cell Cycle Arrest in Bladder Cancer.
12/2013	The inhibition of ferrochelatase enhances 5-aminolevulinic acid-based photodynamic action for prostate cancer.
9/2013	Expression levels of PEPT1 and ABCG2 play key roles in 5-aminolevulinic acid (ALA)-induced tumor-specific protoporphyrin IX (PpIX) accumulation in bladder cancer.
6/2013	Photodynamic therapy involves an antiangiogenic mechanism and is enhanced by ferrochelatase inhibitor in urothelial carcinoma.
6/2012	Overexpression of p53 protein in human tumors.
9/2009	Immunohistochemical and electron microscopy studies of a case of hyalinizing trabecular tumor of the thyroid gland, with special consideration of the hyalinizing mass associated with it.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Atsushi Kurabayashi Research Topics

Disease

20	Neoplasms (Cancer) 02/2022 - 05/2002
8	Urinary Bladder Neoplasms (Bladder Cancer) 06/2022 - 11/2004
4	Ischemia 02/2022 - 12/2011
4	Carcinoma (Carcinomatosis) 03/2020 - 11/2004
4	Prostatic Neoplasms (Prostate Cancer) 08/2015 - 08/2011
3	Body Weight (Weight, Body) 10/2021 - 09/2005
3	Neoplasm Metastasis (Metastasis) 01/2017 - 09/2005
3	Margins of Excision 08/2015 - 08/2011
2	Hypertension (High Blood Pressure) 05/2022 - 03/2020
2	Renal Cell Carcinoma (Grawitz Tumor) 08/2015 - 04/2007
2	Necrosis 12/2013 - 06/2013
2	Aneuploidy (Aneuploid) 01/2012 - 10/2006
2	Hypoxia (Hypoxemia) 12/2011 - 01/2008
2	Esophageal Squamous Cell Carcinoma 01/2004 - 01/2003
1	Non-Muscle Invasive Bladder Neoplasms 06/2022
1	Urologic Neoplasms (Urological Cancer) 02/2022
1	Hemorrhagic Cystitis 01/2022
1	Edema (Dropsy) 01/2022
1	Hemorrhage 01/2022
1	Carcinoma in Situ 03/2020
1	Diabetes Mellitus 05/2018
1	Glucose Intolerance 05/2018
1	Atrophy 07/2014
1	Muscular Atrophy (Muscle Atrophy) 07/2014
1	Hypoglycemia (Reactive Hypoglycemia) 01/2013
1	Hypersensitivity (Allergy) 01/2013
1	Foreign Bodies (Foreign Body) 12/2012
1	Gallbladder Neoplasms (Gallbladder Cancer) 12/2012
1	Granuloma 12/2012
1	Liver Neoplasms (Liver Cancer) 12/2012
1	Adenocarcinoma 12/2012
1	Eosinophilia 12/2012
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 02/2010
1	Histiocytosis 02/2010

Drug/Important Bio-Agent (IBA)

13	AcidsIBA 06/2022 - 07/2006
6	Proteins (Proteins, Gene)FDA Link 06/2012 - 01/2003
3	Pharmaceutical PreparationsIBA 05/2022 - 09/2005
3	Glucose (Dextrose)FDA LinkGeneric 02/2022 - 05/2018
3	Messenger RNA (mRNA)IBA 01/2022 - 01/2012
3	protoporphyrin IXIBA 12/2013 - 01/2009
3	AntibodiesIBA 12/2012 - 12/2007
3	S100 Proteins (S 100 Protein)IBA 09/2009 - 05/2004
2	Aminolevulinic Acid (Levulan)FDA Link 06/2022 - 03/2020
2	Biological ProductsIBA 02/2022 - 09/2005
2	EnzymesIBA 01/2022 - 01/2003
2	SolutionsIBA 03/2020 - 05/2015
2	YM 529IBA 08/2015 - 09/2005
2	Diphosphonates (Bisphosphonates)IBA 08/2015 - 09/2005
2	Ferrochelatase (Heme Synthetase)IBA 12/2013 - 06/2013
2	1-phenyl-3,3-dimethyltriazene (PDT)IBA 12/2013 - 06/2013
2	alanylalanine (Ala-Ala)IBA 11/2013 - 02/2012
2	Tamoxifen FDA LinkGeneric 01/2013 - 01/2008
2	Nitric Oxide (Nitrogen Monoxide)FDA Link 05/2004 - 01/2003
1	Losartan (Cozaar)FDA LinkGeneric 05/2022
1	PorphyrinsIBA 02/2022
1	Tumor Biomarkers (Tumor Markers)IBA 02/2022
1	Reactive Oxygen Species (Oxygen Radicals)IBA 02/2022
1	Photosensitizing Agents (Photosensitizers)IBA 02/2022
1	ferrous citrate FDA Link 01/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2022
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2022
1	Hematoxylin (Haematoxylon)IBA 01/2022
1	Heme (Haem)IBA 01/2022
1	ImmunosorbentsIBA 01/2022
1	Peroxidase (Myeloperoxidase)IBA 01/2022
1	CreatinineIBA 10/2021
1	Blood Glucose (Blood Sugar)IBA 07/2020
1	Tadalafil (Cialis)FDA Link 03/2020
1	silodosin FDA Link 03/2020
1	NitrogenIBA 08/2015
1	Interferon-alpha (Interferon Alfa)IBA 08/2015
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 08/2015
1	Adenosine Triphosphatases (ATPase)IBA 01/2015
1	CyclinsIBA 01/2015
1	Nicotinic Receptors (Nicotinic Acetylcholine Receptor)IBA 07/2014
1	Myosin Heavy Chains (Myosin Heavy Chain)IBA 07/2014
1	Cholinergic Agents (Cholinergics)IBA 07/2014
1	LigandsIBA 07/2014
1	Galantamine (Galanthamine)FDA LinkGeneric 07/2014
1	Donepezil (Aricept)FDA LinkGeneric 07/2014
1	Nicotine FDA Link 07/2014
1	terrestrosin DIBA 01/2014
1	SaponinsIBA 01/2014
1	CaspasesIBA 12/2013
1	Hypoglycemic Agents (Hypoglycemics)IBA 01/2013
1	Insulin ReceptorIBA 01/2013
1	InterleukinsIBA 12/2012
1	Poly AIBA 01/2012
1	Snake Venoms (Snake Venom)IBA 12/2011
1	Angiotensin IIIBA 12/2011
1	Immunoglobulins (Immunoglobulin)IBA 02/2010

Therapy/Procedure

4	Therapeutics 12/2013 - 09/2005
3	Photochemotherapy (Photodynamic Therapy) 02/2022 - 06/2013
3	Prostatectomy (Retropubic Prostatectomy) 08/2015 - 08/2011
2	Transurethral Resection of Bladder 06/2022 - 02/2012
1	Subcutaneous Injections 01/2017
1	Castration 01/2014
1	Cholecystectomy 12/2012
1	Oral Administration 02/2012
1	Laparoscopes (Laparoscope) 08/2011